A platform acquisition buys an operating base intended to support further growth, while an add-on is acquired to fit an existing organization. The labels do not create fixed valuation multiples. Compare management infrastructure, standalone earnings, integration costs, growth requirements, and payment terms before applying one transaction’s price to another practice.
What makes a med spa acquisition a platform?
A platform is an operating base that a purchaser expects to support a broader investment or acquisition plan. It may include leadership, reporting, recruiting, administrative systems, professional relationships, and integration capability. The exact requirements depend on the buyer’s strategy and the business being acquired.
Several locations alone do not prove platform capability. If every site depends on the selling owner, financial reporting is inconsistent, and expansion requires new management, the purchaser still has infrastructure to build. Those costs and dependencies belong in the valuation discussion.
Ask a buyer using the platform label what functions already exist, which must be created, and how the purchase price accounts for them. A credible platform case explains who can run the existing organization and absorb growth without relying on unlimited seller involvement or unbudgeted central spending.
What makes a practice an add-on?
An add-on joins an existing operator or investment platform. It may expand geography, add providers, complement services, increase local density, or use shared administrative resources. The buyer is evaluating fit with its organization as well as the target’s standalone performance.
Some benefits are buyer-specific. Shared purchasing, local management coverage, or marketing systems may create savings, but the buyer still needs evidence that integration can deliver them. The seller should distinguish existing earnings from synergies that have not yet occurred.
An add-on is not necessarily small, weak, or inexpensive. The label describes its role in the acquirer’s plan. A well-run practice with highly transferable earnings may attract strong interest, while a larger practice can be difficult to integrate. Ask what strategic problem the acquisition solves and which alternatives the buyer has.
How should the categories be compared?
Use the table to identify what a published comparable actually includes. Avoid matching a single-site business with a transaction whose price also reflects central management, a brand network, or an acquisition organization.
| Criterion | Platform question | Add-on question |
|---|---|---|
| Management | Can leadership run and expand the organization? | What local management must remain? |
| Reporting | Can systems support multiple sites and integration? | Can records migrate into buyer systems? |
| Growth | What infrastructure supports new locations? | What fit supports existing buyer goals? |
| Costs | Are central functions fully staffed? | What integration costs and savings exist? |
| Clinical continuity | Can the professional structure support the plan? | Can the target operate within it lawfully? |
| Consideration | What equity and future obligations remain? | What cash and contingent terms apply? |
Both need reliable standalone records. A strategic story should explain value beyond the accounts without replacing the obligation to verify the accounts themselves.
Why do public multiple comparisons become misleading?
The earnings denominator may differ. A target’s claimed adjusted EBITDA can omit replacement management, while another business’s EBITDA includes a complete executive team. Some public prices include contingent amounts or investment in the surviving company. Others describe enterprise value before debt and closing adjustments.
The May 2026 AmSpa commentary on 2025 transaction patterns differentiates observations by scale. It is an advisor’s dated perspective, not a transaction database proving a standard premium for every platform. Examine the source’s scope and limits before borrowing a range.
A useful comparable file records the date, business model, scale, earnings basis, geography, control acquired, payment mix, and available disclosures. If those facts are missing, give the comparison less weight. A headline multiple without its denominator and terms is a conversation starter, not an appraisal.
How should central infrastructure affect the math?
Consider an illustrative group whose sites generate $1.2 million contribution before central costs. Existing central payroll and administration total $310,000, but the proposed operating plan needs another $140,000 of management and reporting support. Sustainable group earnings on this defined basis are $1,200,000 − $310,000 − $140,000 = $750,000.
Calling the group a platform does not eliminate that $140,000 requirement. A buyer applying a multiple to $890,000 without recognizing the missing functions would be underwriting a different staffing plan. The adjustment should be supported by the roles actually required, not an arbitrary corporate-cost allowance.
These are invented assumptions for teaching. The contribution measure is not automatically EBITDA, and a full analysis must account for the appropriate income-statement items and normalization. Keep the model’s labels and definitions visible so the same number is not used for incompatible valuation methods.
How should add-on synergies and integration costs be treated?
Start with the target’s verified standalone earnings, then add a separate integration bridge. List anticipated savings, incremental revenue, one-time migration costs, recurring platform charges, and the time required. Identify which assumptions are contractually or operationally supported and which remain forecasts.
For an illustrative add-on producing $280,000 standalone earnings, assume $55,000 achievable recurring savings and $25,000 additional annual support cost. The buyer’s projected result is $310,000 before one-time integration spending. If migration costs $90,000, that investment belongs in the return analysis even though it may not recur.
Do not give the same savings credit twice, once in adjusted earnings and again in a higher strategic multiple. Sellers can negotiate for some strategic value, but the amount depends on competing alternatives and execution risk. A buyer’s internal projection does not automatically become guaranteed purchase consideration.
When should a seller pursue a platform or add-on positioning?
Choose platform positioning when the leadership, systems, professional arrangements, and growth capacity are demonstrable and the buyer’s plan fits them. Be prepared to show central costs, management retention, reporting consistency, and integration experience without inventing a track record.
Choose add-on positioning when the practice offers verified earnings and a specific fit with established operators. Explain the local team, patient retention, services, premises, and continuity needs clearly. A seller need not build an acquisition organization merely to interest a buyer.
Financing capacity still matters. The SBA 7(a) overview describes one eligible acquisition-financing route, not a standard source for every platform deal. Ask each purchaser to document its actual capital plan. A strategic classification has little practical value if the buyer cannot fund and execute the proposed transaction.
What do owners most often get wrong?
Owners sometimes use a platform transaction’s headline multiple as a price entitlement for a business with different staffing and scale. Buyers can make the opposite error by dismissing an add-on’s distinct strengths because it lacks central infrastructure the buyer already owns. Both positions avoid the work of explaining the economics.
Compare the complete offer, including rollover, notes, earnouts, expenses, debt, and continuing work. Ask the CPA to evaluate tax character and allocation; the IRS business-sale guide explains why consideration is not always one undifferentiated tax item. The purchase headline is only one part of the seller outcome.
Use the valuation hub, market evidence guide, seller process, and buyer roadmap to frame the decision. Require a written explanation of what creates value, what must still be built, and who pays for that work after closing.
Use the Four-Number Med Spa Valuation Screen to align earnings, and the offer-to-proceeds bridge to align consideration. Review the valuation multiples guide before comparing transactions. Ask the purchaser to explain whether the proposal pays for existing infrastructure, prospective savings, or a continuing investment by the seller. Those are different sources of value and should remain visible when the headline is converted into definitive terms and a personal cash plan.
What else do owners and buyers ask?
Does owning three locations make my med spa a platform?
No fixed location count establishes that status. Buyers examine leadership, systems, reporting, clinical structure, and the capacity to support growth. A group with several owner-dependent sites may still need substantial infrastructure. Describe the functions that already work and the investment required rather than relying on the number of addresses.
Should an add-on always receive a lower multiple?
There is no universal rule. Price reflects earnings quality, strategic fit, competing buyers, terms, and the market evidence relevant to that business. A target may be unusually useful to a specific acquirer. Compare the actual proposals and avoid applying a standard discount solely because the buyer calls it an add-on.
Can I include the buyer’s savings in my EBITDA?
Present existing standalone earnings separately from prospective buyer synergies. Explain the evidence for each potential saving and the cost and time required to achieve it. Mixing them can create double counting or confuse lender and buyer analysis. Negotiating for strategic value is different from claiming the business already earns it.
Will retained equity pay out when a platform grows?
Growth does not guarantee a distribution or liquidity event. The value reaching your interests depends on the capital structure, rights, leverage, dilution, and transaction terms. Examine the investment documents and downside cases independently. A projected platform exit should remain an uncertain scenario rather than cash assumed available for personal planning.
Which sources support this guide?
Sources were checked during research. Regulations, lender policies, and market conditions can change. Use the linked primary material and your advisors to confirm applicability.
- 2025 med spa M&A observations, published May 2026 — American Med Spa Association / Xite
- 7(a) loans and ownership changes — U.S. Small Business Administration
- Sale of a business — Internal Revenue Service
Educational analysis prepared with AI-assisted research for The Med Spa Broker. “Last reviewed” records the source and editorial check date; it does not imply review by an attorney, clinician, or independent appraiser. Read our editorial standards.